A Phase IIa Open-label, Randomized Study to Compare the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of NM-IL-12 (rHuIL-12) to Standard of Care in Subjects With Open Surgical Wounds Following Colostomy Takedown Allowed to Heal by Secondary Intention

A Phase IIa Open-label, Randomized Study to Compare the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of NM-IL-12 (rHuIL-12) to Standard of Care in Subjects With Open Surgical Wounds Following Colostomy Takedown Allowed to Heal by Secondary Intention